DOT1L in neural development and neurological and psychotic disorders
Neurochemistry International · 2025
DOI: 10.1016/j.neuint.2025.105955 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurochemistry International, 2025. Verfasst von Feiyan Shen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, China;…. Hauptthemen laut MEDLINE: Histone-Lysine N-Methyltransferase, Psychotic Disorders, Neurodevelopmental Disorders, Neurogenesis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 99 Literaturangaben. Gefördert von: Zhejiang Province Natural Science Foundation, Key Research and Development Program of Zhejiang Province.
Abstract (Originalsprache)
Disruptor of Telomeric Silencing 1-Like (DOT1L) is the sole methyltransferase in mammals responsible for catalyzing the mono-, di-, and trimethylation of histone H3 at lysine 79 (H3K79), a modification crucial for various cellular processes, including gene transcription, cell cycle regulation, DNA repair, and development. Recent studies have increasingly linked DOT1L to the nervous system, where it plays a vital role in neurodevelopment and neuronal function. It has been shown to regulate the proliferation and differentiation of neural progenitor cells, promote neuronal maturation, and influence synaptic function, all of which are essential for proper neural circuit formation and brain function. Moreover, dysregulation of DOT1L has been associated with several neurological disorders, highlighting its potential role in disease pathology. Abnormal expression or activity of DOT1L has been implicated in cognitive deficits and neurodegenerative diseases, underscoring the enzyme's significance in both the development and maintenance of the nervous system. This review synthesizes recent findings on DOT1L's role in the nervous system, emphasizing its importance in neurodevelopment and exploring its potential as a therapeutic target for treating neurological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, China; College of Pharmaceutical Sciences, Institute of Pharmacology and Tox…
- Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, China. Electronic address: zenglh@hzcu.edu.cn.
- Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, China. Electronic address: gaoyp@hzcu.edu.cn.
Förderung
- Zhejiang Province Natural Science Foundation
- Key Research and Development Program of Zhejiang Province
Zitieren
APA
Shen, F., Zeng, L., & Gao, Y. (2025). DOT1L in neural development and neurological and psychotic disorders. Neurochemistry International. https://doi.org/10.1016/j.neuint.2025.105955
Vancouver
Shen F, Zeng L, Gao Y. DOT1L in neural development and neurological and psychotic disorders. Neurochemistry International. 2025. doi:10.1016/j.neuint.2025.105955
BibTeX
@article{Shen2025,
author = {Shen, Feiyan and Zeng, Linghui and Gao, Yanpan},
title = {DOT1L in neural development and neurological and psychotic disorders},
journal = {Neurochemistry International},
year = {2025},
doi = {10.1016/j.neuint.2025.105955}
}
EUVIMED